Abstract |
Interleukin 35 (IL-35) is a relatively newly identified cytokine required for the regulatory and suppressive functions of regulatory T cells (Treg), playing an important role in the prevention of autoimmune diseases. This study used mesenchymal stem cells (MSCs) as the gene-delivery vehicles for IL-35 gene therapy and investigated their protective effects in Concanavalin A (Con A)-induced autoimmune hepatitis. Results showed that IL-35 gene modified MSCs (IL-35-MSCs) can specifically migrate to the injured liver tissues and significantly narrow the necrosis areas of injured livers. IL-35-MSCs prevented hepatocyte apoptosis by reducing the FASL expression by mononuclear cells. Although MSC treatment can alleviate liver injury to some extent, IL-35-MSCs showed a stronger protective effect, which means some novel mechanisms exist. The results show that IL-35-MSCs could decrease the level of interferon gamma secreted by liver mononuclear cells through the JAK1-STAT1/STAT4 signal pathway. In summary, this study thus demonstrates a novel and efficient treatment for Con A-induced fulminant hepatitis through negatively regulating the secretion of interferon gamma, thus providing a novel therapeutic approach for this devastating liver disease.
|
Authors | Wei Wang, Hao Guo, Hongyue Li, Yongjia Yan, Chao Wu, Xiaodong Wang, Xianghui He, Na Zhao |
Journal | Human gene therapy
(Hum Gene Ther)
Vol. 29
Issue 2
Pg. 234-241
(02 2018)
ISSN: 1557-7422 [Electronic] United States |
PMID | 29054137
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- FASLG protein, human
- Fas Ligand Protein
- Interleukins
- interleukin-35, human
- Concanavalin A
- Interferon-gamma
- Janus Kinase 1
|
Topics |
- Animals
- Apoptosis
(genetics)
- Concanavalin A
(toxicity)
- Fas Ligand Protein
- Gene Expression Regulation
(genetics)
- Gene Transfer Techniques
- Hepatitis, Autoimmune
(etiology, genetics, therapy)
- Hepatocytes
(metabolism, pathology)
- Humans
- Interferon-gamma
(genetics)
- Interleukins
(genetics, therapeutic use)
- Janus Kinase 1
(genetics)
- Liver
(metabolism, pathology)
- Liver Failure, Acute
(chemically induced, genetics, pathology, therapy)
- Male
- Mesenchymal Stem Cell Transplantation
- Mesenchymal Stem Cells
(cytology)
- Mice
- T-Lymphocytes, Regulatory
(metabolism, pathology)
|